[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"body-composition-changes\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:body-composition-changes":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,9,0,[8,48,75,88,116,150,171,205,238],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":30,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":47},"100054036","nutritional-supplementation-on-physiological-and-metabolic-markers-in-females-100054036",false,"NCT07615777","Nutritional Supplementation on Physiological and Metabolic Markers in Females","A Pilot Study Investigating the Effects of a Nutritional Supplement on Physiological and Metabolic Markers in 38-55-year-old Females","Inclusion Criteria:\n\n* Assigned sex at birth is female\n* Aged 38-55 years\n* Experiencing irregular menstrual cycles but not amenorrheic for more than 12 months or have at least one of the following recent symptoms (i.e., from 38 years onwards): (1) hot flushes, (2) sleep disturbances, (3) mood swings, (4) concentration difficulties, (5) bloating or (6) weight gain.\n\n  * Willing to avoid taking other food supplements during the study period\n  * Able to provide written informed consent\n\nExclusion Criteria:\n\n* Diabetes\n* BMI \\\u003C18.5 kg\u002Fm2\n* Pregnant or trying to get pregnant\n* No active cancer or cancer within last 5 years\n* Total Hysterectomy\n* Known allergies to cinnamon extract, chromium, berberine, myo-inositol\n* Currently taking part in research, or have done within the last 3 months\n* Diagnosed autoimmune diseases\n* Diagnosed hypoglycemia",true,"FEMALE","38 Years","55 Years",{"count":21,"type":22},80,"ESTIMATED","INTERVENTIONAL",[25],"NA","The goal of this clinical trial is to learn if a 12-week nutritional supplement can result in significant changes in the body composition of 38-55-year-old females. The main questions it aims to answer are:\n\n* Does a 12-week nutritional supplementation with myo-inositol, berberine, cinnamon, and chromium lead to significant changes in body composition (e.g. body mass index, body fat composition) in females aged 38-55 compared to placebo?\n* Does a 12-week nutritional supplementation with myo-inositol, berberine, cinnamon, and chromium lead to significant changes in small molecules (metabolites) in plasma and urine, menopause-related symptoms, and physical performance (e.g. grip strength) in females aged 38-55 compared to placebo? Researchers will compare the nutritional supplement to a placebo (a look-alike substance that contains no nutritional supplement) to see if the intervention works to change body composition in females aged 38-55.\n\nParticipants will:\n\n* Sign a consent form before any procedures begin\n* Attend two visits to the clinical research facility at Southampton General Hospital over 12 weeks.\n* Fast before visit's and provide blood and urine samples at each visit\n* Undergo measurements at each visit, including waist and hip circumferences, grip and leg strength, and body composition.\n* Complete questionnaires about general health, menopause-related changes, alcohol consumption, physical activity, and diet.\n* Take 1 capsule 3 times a day at the onset of a meal (once in the morning, once at midday, and once in the evening) for the first 10 days.\n* Take 3 capsules 3 times a day at the onset of a meal (once in the morning, once at midday, and once in the evening) from day 11 to day 84.\n* Record supplement intake in a daily compliance diary during the study",[28,29],"Perimenopausal Women","Body Composition Changes",[31,32,33,34],"Perimenopause","menopause","metabolism","metabolomics","RECRUITING","2026-07-10",{"date":38,"type":39},"2026-07-13","ACTUAL",{"date":41,"type":39},"2026-07-09",{"date":43,"type":22},"2026-12",{"name":45,"class":46},"University of Southampton","OTHER",1,{"id":49,"slug":50,"hasResults":11,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":11,"sex":17,"minAge":56,"maxAge":4,"enrollmentInfo":57,"targetDuration":4,"studyType":59,"phases":4,"briefSummary":60,"conditions":61,"keywords":4,"overallStatus":65,"whyStopped":4,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":4},"100644996","health-body-composition-and-nutrition-research-among-women-in-kazakhstan-100644996","NCT07675486","Health, Body Composition, and Nutrition Research Among Women in Kazakhstan","Understanding Women's Health in Kazakhstan: Body Composition as a Key Indicator for Precision Nutrition and Predictive Healthcare","HER-KZ","Inclusion Criteria:\n\n* Female sex\n* Age ≥20 years at the time of consent\n* Natural postmenopause (≥12 consecutive months of amenorrhoea not attributable to other pathological or pharmacological causes) OR surgical postmenopause (bilateral oophorectomy)\n* Resident of Astana or the surrounding region with no planned relocation during the study period\n* Able to provide written informed consent independently\n* Able to complete the questionnaire in Kazakh, Russian, or English\n\nExclusion Criteria:\n\n* Active malignancy or systemic anti-cancer treatment (chemotherapy, radiotherapy, immunotherapy) within the past 5 years\n* Conditions causing secondary changes in muscle mass or body composition: hyperthyroidism (untreated), Cushing's syndrome, acromegaly, severe liver disease (Child-Pugh B or C), advanced chronic kidney disease (Stage 4 or 5, eGFR \\\u003C30 ml\u002Fmin\u002F1.73 m²)\n* Neuromuscular disorders that independently affect skeletal muscle mass (e.g., myopathy, motor neurone disease, multiple sclerosis)\n* Long-term systemic corticosteroid therapy (\\>3 months in the past year, equivalent to ≥5 mg\u002Fday prednisolone)\n* Severe skeletal deformity (kyphoscoliosis, limb absence) or presence of metallic implants (hip or knee prosthesis on both sides, bilateral rods) that would significantly compromise DEXA body composition validity\n* Physical inability to stand or to complete the functional assessments safely\n* Cognitive impairment or psychiatric condition precluding independent informed consent, as determined by the recruiting research team member","20 Years",{"count":58,"type":22},200,"OBSERVATIONAL","This study aims to investigate the association between dietary intake, physical activity, sleep quality, and body composition in women in Kazakhstan. The study will recruit approximately 200 women aged 20 years and older undergoing routine DEXA examinations in Astana. Participants will complete validated questionnaires assessing diet, physical activity, sleep quality, and sarcopenia risk, alongside functional assessments. DEXA scans will provide measurements of fat mass, lean mass, visceral adipose tissue, bone mineral density, and appendicular skeletal muscle mass. The primary objective is to evaluate associations between dietary quality and DEXA-derived outcomes. Secondary objectives include assessing sarcopenia prevalence and examining relationships between physical activity, sleep quality, supplement use, and body composition. An optional second stage will explore associations between body composition and existing inflammatory and metabolic biomarkers from medical records. The findings are expected to provide the first comprehensive DEXA-based dataset on women's body composition and lifestyle factors in Kazakhstan and inform public health strategies.",[29,62,63,64],"Dietary Intakes","Sleep","Physical Activity","NOT_YET_RECRUITING","2026-06-26",{"date":68,"type":39},"2026-06-30",{"date":70,"type":22},"2026-07",{"date":72,"type":22},"2029-07",{"name":74,"class":46},"Nazarbayev University",{"id":76,"slug":4,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":77,"targetDuration":4,"studyType":23,"phases":78,"briefSummary":26,"conditions":79,"keywords":80,"overallStatus":65,"whyStopped":4,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":87,"locationsCount":47},"100640067",{"count":21,"type":22},[25],[28,29],[31,32,33,34],"2026-05-29",{"date":83,"type":39},"2026-06-03",{"date":85,"type":22},"2026-06-01",{"date":43,"type":22},{"name":45,"class":46},{"id":89,"slug":90,"hasResults":11,"nctId":91,"briefTitle":92,"officialTitle":93,"acronym":94,"eligibilityCriteria":95,"healthyVolunteers":16,"sex":17,"minAge":96,"maxAge":4,"enrollmentInfo":97,"targetDuration":4,"studyType":23,"phases":99,"briefSummary":100,"conditions":101,"keywords":4,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":107,"lastUpdatePostDateStruct":108,"startDateStruct":110,"completionDateStruct":112,"leadSponsor":114,"locationsCount":47},"100637190","effect-of-dairy-protein-yogourt-vs-plant-based-yogourt-on-body-weight-body-composition-bone-health-and-gut-microbiota-100637190","NCT07578103","Effect of Dairy Protein Yogourt vs Plant-based Yogourt on Body Weight, Body Composition, Bone Health and Gut Microbiota","A New Focus on Protein and the Gut Microbiota to Explain Health Benefits of Dairy Foods","PROYO","Inclusion Criteria:\n\n* Postmenopausal women (absence of menstruation for at least 1 year and FSH \\> 40 IU\u002FL)\n* BMI between 27.0 and 39.9 kg\u002Fm²\n* Sedentary or moderately active\n\nExclusion Criteria:\n\n* Body weight change greater than 5 kg in the 3 months preceding the study\n* Currently dieting or following specific dietary patterns\n* Previous or planned bariatric surgery\n* Food allergies or intolerances (particularly dairy proteins and lactose)\n* Serious or problematic health conditions (e.g., renal insufficiency, diabetes, Cushing's disease, Paget's disease, parathyroid disorders, inflammatory bowel disease, uncontrolled thyroid disease, etc.)\n* Fracture within the past year\n* Hormone therapy\n* Medications affecting bone metabolism (e.g., osteoporosis treatments, anti-estrogen therapy for breast cancer, epilepsy treatments)\n* Antibiotic use within the 6 months preceding the study\n* Use of probiotic supplements (capsules)\n* More than two alcoholic drinks per day\n* Smoking\n* Drug abuse","40 Years",{"count":98,"type":22},75,[25],"The consumption of an adequate quantity of protein in the diet is essential to maintain a healthy body composition and functioning. It is also well established that all proteins are not equal regarding their ability to promote health benefits. Recently, we have innovated in that matter by showing that under the context of high intake of dietary fat, the dairy protein casein was more effective than a mix of proteins representative of a western diet to prevent body weight gain and insulin resistance. This was explained in part by modifications of the gut microbiota. This finding represents the main conceptual basis of the present research program that is aimed to determine the impact of dairy protein from yogurt compared to a plant-based equivalent on body composition indicators including muscle mass and bone mineral density, in relation to the profile of the gut microbiota, the production of newly discovered protein-derived metabolites, and markers of metabolic health. This program will include a human and an animal component requiring the testing of these variables before and after a standardized intervention. The human component will be a clinical study consisting of a 12-week diet-based weight loss intervention in postmenopausal overweight women being randomly assigned to one of the three following groups: yogurt, plant-based yogurt, or kept on diet without supplements. The animal experimentation will permit to causally determine the implication of the gut microbiota in the protein effects following transfer of the human bacteria to germ free mice and validate the benefits seen in humans. It is anticipated that these two complementary investigative approaches will allow a thorough documentation of the impact of fermented dairy protein on body composition and functioning, a better understanding of the underlying mechanisms, and the identification of new biomarkers to better appreciate related health benefits.",[29,102,103,104,105,106],"Body Weight Change","Metabolic Health","Bone Metabolism","Bone Health","Gut Microbiota","2026-05-05",{"date":109,"type":39},"2026-05-11",{"date":111,"type":39},"2023-11-01",{"date":113,"type":22},"2026-12-31",{"name":115,"class":46},"Laval University",{"id":117,"slug":118,"hasResults":11,"nctId":119,"briefTitle":120,"officialTitle":121,"acronym":122,"eligibilityCriteria":123,"healthyVolunteers":11,"sex":124,"minAge":125,"maxAge":126,"enrollmentInfo":127,"targetDuration":129,"studyType":59,"phases":4,"briefSummary":130,"conditions":131,"keywords":133,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":141,"lastUpdatePostDateStruct":142,"startDateStruct":144,"completionDateStruct":146,"leadSponsor":148,"locationsCount":47},"100605452","body-composition-assessment-and-monitoring-in-inflammatory-bowel-disease-100605452","NCT07162701","Body Composition Assessment and Monitoring in Inflammatory Bowel Disease","Body Composition Assessment and Monitoring With Bioelectrical Impedance Analysis to Predict Medical Therapy Efficacy in Inflammatory Bowel Disease (the BAMBIE Study)","BAMBIE","Inclusion Criteria:\n\n* Any sex.\n* Age between 18 and 64 years.\n* Patients with a definitive diagnosis (\\>3 months) of Crohn's disease or ulcerative colitis, according to European Crohn's and Colitis Organization criteria.\n* Moderate-to-severe disease luminal activity, with an indication for biologic or JAKi therapy for the induction of clinical remission.\n\nExclusion Criteria:\n\n* Unclassified IBD.\n* History of intestinal resection for IBD, with the exception of ileocecal resection.\n* Short bowel syndrome.\n* Indication for medical treatment due to postsurgical recurrence.\n* Active perianal disease.\n* Indication for medical treatment due to intestinal stricture.\n* Previous participation in a clinical trial involving medication for IBD treatment.\n* Engaging in vigorous physical activity (\\>6 Metabolic Equivalent of Task, METs) for more than 3 days per week.\n* Habitual alcohol consumption (\\>1 standard drink unit\u002Fday).\n* Diabetes mellitus with inadequate glycemic control.\n* Chronic use of diuretics.\n* Chronic kidney disease on dialysis.\n* Presence of dependent edema and\u002For ascites.\n* Cardiac pacemaker bearers.\n* Pregnant or lactating women.\n* Inability to sign informed consent.","ALL","18 Years","64 Years",{"count":128,"type":22},48,"12 Months","This is a single-center, prospective observational study aiming to describe changes in body composition (specifically, percentage of lean mass and phase angle) in patients with active inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease.\n\nThe study will recruit patients with a confirmed IBD diagnosis who are starting biologic therapy or Janus kinase inhibitors (JAKi) to induce clinical remission. Body composition will be assessed using bioelectrical impedance analysis (BIA) at baseline (time 0), 24 weeks, and 52 weeks after starting medication. Clinical disease activity, endoscopic findings, and laboratory data will also be collected at various time points if available.\n\nThe study has a total duration of 36 months, including a 12-18 month patient inclusion period and a 12-month follow-up. Patients will provide informed consent, and all treatment decisions will follow standard clinical practice, as this is a non-interventional observational study.",[29,132],"Malnutrition",[134,135,136,137,138,139,140],"malnutrition","IBD","BIA","composition","body","Crohn","colitis","2025-09-08",{"date":143,"type":39},"2025-09-09",{"date":145,"type":39},"2025-07-15",{"date":147,"type":22},"2028-07-15",{"name":149,"class":46},"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau",{"id":151,"slug":152,"hasResults":11,"nctId":153,"briefTitle":154,"officialTitle":154,"acronym":4,"eligibilityCriteria":155,"healthyVolunteers":16,"sex":124,"minAge":125,"maxAge":4,"enrollmentInfo":156,"targetDuration":4,"studyType":59,"phases":4,"briefSummary":158,"conditions":159,"keywords":4,"overallStatus":65,"whyStopped":4,"lastUpdateSubmitDate":163,"lastUpdatePostDateStruct":164,"startDateStruct":165,"completionDateStruct":167,"leadSponsor":169,"locationsCount":47},"100605334","changes-in-body-composition-of-patients-with-obesity-related-tumors-and-their-impact-on-clinical-outcomes-a-multicenter-prospective-cohort-study-100605334","NCT07161167","Changes in Body Composition of Patients With Obesity Related Tumors and Their Impact on Clinical Outcomes: a Multicenter Prospective Cohort Study","Inclusion Criteria:\n\n1. Age ≥18 years, regardless of gender.\n2. Histologically or cytologically confirmed obesity-associated malignant tumors (e.g., breast cancer, colorectal cancer, gastric cancer, lung cancer, or thyroid cancer) with planned treatment after diagnosis (any treatment modality permitted).\n3. No prior chemotherapy, radiotherapy, biologic therapy, immunotherapy, or other antitumor treatments for malignancy.\n\nExclusion Criteria:\n\n1. Patients with concurrent non-obesity-related malignancies.\n2. History of prior malignancy (except completely cured carcinoma in situ of the cervix, basal cell carcinoma, or squamous cell carcinoma of the skin).\n3. Patients with concurrent multiorgan dysfunction syndrome, autoimmune diseases, infectious diseases, neurological disorders, or psychiatric disorders.",{"count":157,"type":22},6743,"Over the past 20 years, China's obesity rates have surged, increasing cancer burden. Obesity links to 13 cancers via metabolic effects of visceral fat and insulin resistance, while sarcopenic obesity (BMI-independent) may worsen outcomes. Traditional BMI lacks precision; advanced methods (e.g., BIA\u002FCT) are needed. Existing studies show inconsistent results, possibly due to heterogeneity. This multicenter prospective cohort study uses imaging to assess body composition changes (fat\u002Fmuscle) in obesity-related tumors and their impact on survival, recurrence, and quality of life, and explore the underlying mechanism.",[160,29,161,162],"Obesity Rekated Cancer","Survival","Mechanism","2025-09-03",{"date":141,"type":39},{"date":166,"type":22},"2025-09-15",{"date":168,"type":22},"2030-09-30",{"name":170,"class":46},"Peking Union Medical College Hospital",{"id":172,"slug":173,"hasResults":11,"nctId":174,"briefTitle":175,"officialTitle":176,"acronym":177,"eligibilityCriteria":178,"healthyVolunteers":16,"sex":124,"minAge":179,"maxAge":180,"enrollmentInfo":181,"targetDuration":4,"studyType":23,"phases":183,"briefSummary":184,"conditions":185,"keywords":187,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":196,"lastUpdatePostDateStruct":197,"startDateStruct":199,"completionDateStruct":201,"leadSponsor":203,"locationsCount":47},"100575839","the-precision-nutrition-new-york-study-100575839","NCT06777498","The Precision Nutrition New York Study","Optimizing Dietary Fiber Eating Patterns to Prevent Obesity and Resulting Metabolic Disorders","PNNY","Inclusion Criteria:\n\n* Age is between 21-50 years\n* BMI is between 25-30. You can check your BMI here: https:\u002F\u002Fwww.cdc.gov\u002Fbmi\u002Fadult-calculator\u002Findex.html\n* Must be able to have height, weight, waist, and hip circumference, and body composition measured during the study\n* Must be able to provide saliva samples.\n* Must be able to provide a phone number and email address at which the study investigators can contact for study-related matters.\n* Must be able to increase dietary fiber intake to the recommended level following the instructions on the USDA MyPlate website: https:\u002F\u002Fwww.myplate.gov\u002Fmyplate-plan\n* Must be able to provide food records of everything consumed (food, beverage, and supplements) on one weekday and one weekend day (example Tuesday, Saturday) every week during the study. This will be done using an online survey.\n* Must be able to provide 10 stool samples over 11 weeks of the study duration. 18) Must have stable weight (within ±3% of usual body weight) for the last two months.\n* Must be able to to take an online survey to assess recent dietary fiber intake to determine eligibility.\n\nExclusion Criteria:\n\n* Electronic medical implant, for example, a pacemaker.\n* An existing, UNTREATED, thyroid condition.\n* Use of systemic antibiotics (intravenous injection, intramuscular, or oral) within the last 4 months.\n* An acute disease at the time of enrollment (Acute disease is defined as the presence of a moderate or severe illness with or without fever).\n* A chronic, clinically significant (unresolved, requiring ongoing medical management or medication) pulmonary, cardiovascular, gastrointestinal, hepatic, or renal functional abnormality.\n* Any suspected state of immunosuppression or immunodeficiency including HIV.\n* A history of active UNTREATED gastrointestinal disorders or diseases including\n\n  1. Inflammatory bowel disease (IBD)\n  2. Ulcerative colitis (mild-moderate-severe)\n  3. Crohn's or celiac disease\n  4. Indeterminate colitis\n  5. Irritable bowel syndrome (IBS) (moderate-severe)\n  6. Persistent, infectious gastroenteritis, colitis or gastritis\n  7. Persistent or chronic diarrhea of unknown etiology\n  8. Clostridium difficile infection (recurrent)\n  9. Chronic constipation\n* Previously had bariatric surgery.\n* An unstable dietary history as defined by major changes in diet during the previous month. For example, elimination or significantly increased intake of a major food group in the diet.\n* Recent history of chronic alcohol consumption defined as more than 5 drinks (or servings) of alcohol per day.\n* Female participants: pregnant\u002Flactating.","21 Years","50 Years",{"count":182,"type":22},15,[25],"Dietary fiber has been shown to have beneficial effects on human health through its impact on microbes present in the gut. However, these effects can vary between individuals, and everyone may not reap the same health benefits by eating the same sources of fiber. Factors predicting how an individual's gut microbes as well as the beneficial metabolites produced by these microbes change in response to different sources of fiber would be helpful in developing precision nutrition approaches that maximize the benefits of dietary fiber. The objective of this study is to evaluate candidate predictors of gut microbiota response to fiber sources from either whole grains or fruits and vegetables.",[29,186],"Body Weight Changes",[188,189,190,191,192,193,194,195],"dietary fiber","gut microbiome","gut microbiota","short-chain fatty acids","SCFAs","whole grains","fruits","vegetables","2025-07-09",{"date":198,"type":39},"2025-07-11",{"date":200,"type":39},"2025-01-13",{"date":202,"type":22},"2025-12-31",{"name":204,"class":46},"Cornell University",{"id":206,"slug":207,"hasResults":11,"nctId":208,"briefTitle":209,"officialTitle":209,"acronym":4,"eligibilityCriteria":210,"healthyVolunteers":16,"sex":124,"minAge":125,"maxAge":211,"enrollmentInfo":212,"targetDuration":4,"studyType":59,"phases":4,"briefSummary":213,"conditions":214,"keywords":219,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":229,"lastUpdatePostDateStruct":230,"startDateStruct":232,"completionDateStruct":234,"leadSponsor":236,"locationsCount":47},"100568382","the-role-of-nutrition-in-muscle-function-of-bariatric-surgery-patients-100568382","NCT06680492","The Role of Nutrition in Muscle Function of Bariatric Surgery Patients","Inclusion Criteria:\n\n* Male and female\n* Aged 18 to 65 years old\n* Undergoing first bariatric surgery (any type)\n* Diabetics and non-diabetics\n* Non-smokers and non-cannabis consumers\n\nExclusion Criteria:\n\n* Pregnant and breastfeeding women\n* Individuals undergoing second bariatric surgery\n* Regular smokers and cannabis consumers\n* Current use of Ozempic (or Ozempic-like medication) and anti-psychotic meds\n* Limited physical mobility (using walking aids such as canes, walkers, or wheelchairs) and issues with hand resistance\n* Kidney disease, non-controlled \u002F unstable hypertension and hypothyroidism, and any metabolic disease other than diabetes","65 Years",{"count":98,"type":22},"Current recommendations for protein intake after bariatric surgery are not based on strong scientific evidence. It remains unclear how much protein should be eaten to minimize muscle loss and preserve the metabolism and function of individuals post-bariatric surgery.\n\nThe objective of this study is to analyze the relationships between changes in body composition, nutrition and protein intake, and muscle function after bariatric surgery to further our understanding of the nutritional needs of patients after bariatric surgery.\n\nWe intend to recruit around 75 participants, men and women, aged between 18 and 65 years. Participants will be recruited from the Bariatric Surgery Clinic, McGill University Health Center.",[215,29,216,217,218],"Obesity, Diabetes, Nutrition, Physical Health","Muscle Function, Handgrip Strength Test","Protein Metabolism","Bariatric Surgery Patients",[220,221,222,223,224,225,226,227,228],"Obesity","Bariatric sugery","Protein function","Muscle function","6-Minute Walk Test","Handgrip Strength Test","Nutritional needs","Nutritional guides","Nutrition","2024-11-06",{"date":231,"type":39},"2024-11-08",{"date":233,"type":39},"2017-06-23",{"date":235,"type":22},"2026-01",{"name":237,"class":46},"Concordia University, Montreal",{"id":239,"slug":240,"hasResults":11,"nctId":241,"briefTitle":242,"officialTitle":243,"acronym":244,"eligibilityCriteria":245,"healthyVolunteers":11,"sex":124,"minAge":246,"maxAge":4,"enrollmentInfo":247,"targetDuration":249,"studyType":59,"phases":4,"briefSummary":250,"conditions":251,"keywords":4,"overallStatus":65,"whyStopped":4,"lastUpdateSubmitDate":255,"lastUpdatePostDateStruct":256,"startDateStruct":258,"completionDateStruct":260,"leadSponsor":262,"locationsCount":47},"100564559","body-composition-in-older-adults-100564559","NCT06630754","Body Composition in Older Adults","An Exploration of Body Composition in Older Adults Undergoing Systemic Anticancer Treatment.","BODI","Inclusion Criteria:\n\n* Adults eligible and accepting of assessment in the SAOP.\n\n  1. adults aged 70 years and over\n  2. a cancer diagnosis\n  3. just starting SACT\n  4. able to provide at least 2 data sets during the study period (baseline + at least 1 research clinic visit)\n  5. willing and able to provide written informed consent\n\nExclusion Criteria:\n\n* No further exclusions","70 Years",{"count":248,"type":22},30,"1 Day","The primary aim of the study is to explore body composition in older adults (aged 70 years and over) with cancer, undergoing systemic anticancer treatment. Additional aims include to explore the extent of body composition changes and whether changes are tumour specific, the incidence for cancer-related cachexia and sarcopenia and finally, how body composition can inform nutritional management of older adults with cancer.\n\nTo do this, the investigators applied for and were awarded funding from a company called Nutricia to pay for a band 4 (0.6 WTE for 7 months) to take monthly body composition measures on the patients who are eligible, accepting of assessment by the Senior Adult Oncology Programme (SAOP) and consent to these measures. Measurements will include an analysis from the Bioelectrical Impedance Analysis (BIA) machine which will quantify fat, lean muscle, and water content; waist to hip ratio; handgrip strength; calf circumferences. Socio-demographic data will also be collected.\n\nDescriptive data analysis will take place to explore possible trends and associations which may inform future research and drive even further personalised care for this growing and typically underrepresented in research, population.",[252,253,29,254,228],"Sarcopenia in Elderly","Cachexia; Cancer; Sarcopenia","Older Adults","2024-10-04",{"date":257,"type":39},"2024-10-08",{"date":259,"type":22},"2024-11-01",{"date":261,"type":22},"2025-06-01",{"name":263,"class":46},"Royal Marsden NHS Foundation Trust"]